A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)

AIF Moreno, MJG Navarro, JO Sánchez… - European journal of …, 2016 - Elsevier
Background In patients with unprovoked venous thromboembolism (VTE), the optimal
duration of anticoagulation is anchored on estimating the risk of disease recurrence. We …
被引用次数：64 相关文章
[PDF] postersessiononline.eu

[PDF][PDF] A RISK SCORE FOR PREDICTION OF RECURRENCE IN PATIENTS WITH UNPROVOKED VENOUS THROMBOEMBOLISM (DAMOVES)

AIF Moreno, MJG Navarro, JO Sánchez, RMM Díaz… - postersessiononline.eu
Background: Page 1 ISTH 2015 Poster presented at : 485-TU E-PO Ana Isabel Franco D OI:
10.3252/pso.eu.ISTH 2015.2015 R isk factors venous thrombosis A RISK SCORE FOR …

[引用][C] A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)

AI Franco Moreno… - … Journal of Internal …, 2016 - produccioncientifica.ucm.es
Background In patients with unprovoked venous thromboembolism (VTE), the optimal
duration of anticoagulation is anchored on estimating the risk of disease recurrence. We …

A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)

AIF Moreno, MJG Navarro, JO Sánchez… - European Journal of …, 2016 - ejinme.com
Background In patients with unprovoked venous thromboembolism (VTE), the optimal
duration of anticoagulation is anchored on estimating the risk of disease recurrence. We …

A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)

AIF Moreno, MJG Navarro, JO Sánchez… - European Journal of …, 2016 - infona.pl
In patients with unprovoked venous thromboembolism (VTE), the optimal duration of
anticoagulation is anchored on estimating the risk of disease recurrence. We aimed to …

A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES).

FM AI, GN MJ, MD RM, CL de Ancos Aracil… - European Journal of …, 2016 - europepmc.org
Background In patients with unprovoked venous thromboembolism (VTE), the optimal
duration of anticoagulation is anchored on estimating the risk of disease recurrence. We …

A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)

AIF Moreno, MJG Navarro… - … journal of internal …, 2016 - pubmed.ncbi.nlm.nih.gov
Background In patients with unprovoked venous thromboembolism (VTE), the optimal
duration of anticoagulation is anchored on estimating the risk of disease recurrence. We …